C57BL/6JGpt-Tg(Cd8a-iCre)19/Gpt
Tg(Cd8a-iCre )|Strain NO.T007005
Transgenic (Tg)
- Product Type:
- Quantity: - +
- Sex:
- Age:
- Genotype:
BASIC INFORMATION
| Strain Name: | C57BL/6JGpt-Tg(Cd8a-iCre)19/Gpt |
| Strain Number: | T007005 |
| Official Symbol: | Cd8a,iCre |
| Strain Strategy: | T007005.Cd8a-iCre-polyA BAC-TG Strategy-EN.pdfT007005.Tg(Cd8a-iCre) strain info.pdf |
| Official Full Name: | CD8 antigen, alpha chain |
| Also Known As: | BB154331,Ly-2,Ly-35,Ly-B,Lyt-2 |
| NCBI Number: | 12525 |
| MGI Number: | 88346 |
| Research Areas: | Tool Mice,Cre/Dre |
| Strain Background: | [N000013] C57BL/6JGpt |
| Modification Type: | Transgenic (Tg) |
| Genotyping Protocols: | T007005.Cd8a-iCre Genotyping Protocol(TG).pdf |
| Inventory Status: | Live,Cryopreserved |
| Sale Status: | IF (Available for Distribution) |
| Health Status: | Specific pathogen free (SPF) |
| Publications: | 1. Glycolysis inhibition induces anti-tumor central memory CD8(+)T cell differentiation upon combination with microwave ablation therapy |
| Gene Family: | CD moleculesV-set domain containing |